Exel WhitePaper - Transformation Of The U.S. Medical Device Supply Chain - An Evolution In America's Healthcare

Business as usual ended in 2013 for the U.S. Medical Device industry due to a number of factors including:

• Implementation of The Affordable Care Act
• A 2.3 percent federal excise tax on medical devices
• Intense price pressures from payers
• A payer- driven shift in performance requirements

As a result, device manufacturers are discovering that while the supply chain delivers extraordinary service – it does so at an unsustainable pace. That is why companies are rethinking everything – including their supply chains.

The research-based white paper, Transformation of the U.S. Medical Device Supply Chain, discusses current market trends, the impact to the supply chain and the strategies, practices and solutions to address these developments. Read the paper to learn valuable insights into the way forward for the new medical device supply chain in the U.S. market.